The mechanics of chart reporting are the same whether you are one artist or forty. What changes at roster scale is the risk, the scheduling, and who is making the promises. This article covers the label-specific part.

For the basics, including how to opt a release in and the pricing and metadata requirements, start with How Do I Get My Sales Reported to the Billboard Charts?

There is no account-level setting that opts your whole catalogue in. Each release is designated as chart-eligible individually in Backstage.

On a busy release schedule this is the step that gets missed, and it cannot be applied retroactively once a chart week has closed. Build it into your release checklist rather than relying on anyone remembering.

When you opt a release in, you are confirming that you hold all the rights necessary and that the release meets Luminate's minimum pricing.

On a Label Account you are making that representation for an artist rather than about your own work. It is worth being certain of the underlying rights position before you opt in, particularly on catalogue you acquired rather than signed directly.

Luminate limits chart-eligible direct-to-consumer digital exclusives to one per artist per week.

The limit is per artist, so it constrains scheduling rather than volume across your roster. Two artists can run exclusives in the same week. One artist cannot. If you are staggering a campaign across deluxe editions or variants for the same artist, map that against chart weeks before you commit to dates.

Chart weeks run Friday through Thursday.

Every release needs a valid UPC and an ISRC on every track. EVEN does not issue either.

If your releases arrive through DDEX from your distributor, the metadata comes with them, and you remain responsible for its accuracy. Bad or missing codes are the most common reason a sale fails validation, and at roster scale a systematic metadata problem in your delivery pipeline will quietly cost you across every release rather than one.

It is worth auditing a sample of deliveries rather than assuming the pipeline is clean.

This is the part worth reading twice.

Chart reporting depends on EVEN's certification with Luminate. If data anomalies on your account trigger a suspension of that certification, EVEN may suspend chart reporting for your account while we investigate, and terminate the account where we find fraudulent activity.

On a Label Account, that exposure sits at the account level. One artist's irregular sales activity can affect chart reporting for everyone else on your roster, including artists who did nothing wrong.

Practically, this means anything that artificially inflates sales is not a contained risk you are taking on one campaign. If you have any doubt about activity on a release, tell us before a chart week closes rather than after.

Once sales data has been reported, Luminate holds a perpetual, irrevocable licence to it and it cannot be retracted.

If you pull a release from sale partway through a reporting period, sales already submitted for that period stand.

Luminate sets these standards, not EVEN, and revises them from time to time. We communicate material changes through Backstage, and we may modify or discontinue chart reporting where the rules require it.

If you plan campaigns months ahead, check the current requirements at setup rather than working from what applied to your last release.

If charting is a priority on a release, email [email protected] with the artist name, the release and your target date, and loop us in before the campaign is announced rather than after.

We can confirm what was reported on a given campaign and flag anything that failed validation.